NCT02177110View on ClinicalTrials.gov

A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or Metastatic Malignant Melanoma

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2020

Conditions

Advanced MelanomaMetastatic Melanoma

Trial Locations (6)

Unknown

Cork University Hospital, Cork

Beaumont Hosptial, Dublin

Mater Misericordiae University Hospital and Mater Private Hospital, Dublin

St Vincent's University Hospital, Dublin

Galway University Hospital, Galway

Waterford Regional Hospital, Waterford

All Listed Sponsors

lead

Cancer Trials Ireland

NETWORK

NCT02177110 - A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or Metastatic Malignant Melanoma | Biotech Hunter | Biotech Hunter